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Coat protein (CP) of alfalfa mosaic virus (AMV) binds as a dimer to the 39 termini of the three genomic RNAs and is required
for initiation of infection, asymmetric plus-strand RNA accumulation, virion formation, and spread of the virus in plants. A
mutational analysis of the multiple functions of AMV CP was made. Mutations that interfered with CP dimer formation in the
two-hybrid system had little effect on the initiation of infection or plus-strand RNA accumulation but interfered with virion
formation and reduced or abolished cell-to-cell movement of the virus in plants. Six of the 7 basic amino acids in the
N-terminal arm of CP (positions 5, 6, 10, 13, 16, and 25) could be deleted or mutated into alanine without affecting any step
of the replication cycle except systemic movement in plants. Mutation of Arg-17 interfered with initiation of infection (as
previously shown by others) and cell-to-cell movement of the virus but not with plus-strand RNA accumulation or virion
formation. The results indicate that in addition to the RNA-binding domain, different domains of AMV CP are involved in
initiation of infection, plus-strand RNA accumulation, virion formation, cell-to-cell movement, and systemic spread of the
virus. © 2000 Academic PressINTRODUCTION
The vast majority of plant viruses have a positive-
strand RNA genome of messenger sense polarity that is
encapsidated by a single type of coat protein (CP) (Mat-
thews, 1991). The major function of the CP is believed to
be to protect the viral RNA within the infected cell and to
permit transmission of the viral genome from plant to
plant, either mechanically or by vectors such as insects,
nematodes, or fungi. For a number of plant viruses, CP is
required for cell-to-cell movement of the viral RNA
through modified plasmodesmata, whereas other vi-
ruses are able to spread at wild-type (WT) levels in the
inoculated leaf when expression of the CP gene is
blocked. On the other hand, for most plant viruses CP is
required for systemic movement of the virus from leaf-
to-leaf through the vascular system of the plant (re-
viewed in Carrington et al., 1996). The CP of the genera
Alfamovirus and Ilarvirus within the family Bromoviridae
is unique among plant viruses in being required for two
additional steps in the viral replication cycle. In 1971, it
was observed that a mixture of the three genomic RNAs
of alfalfa mosaic virus (AMV, the type species of the
alfamoviruses) was not infectious to plants unless a few
molecules of CP were added per RNA molecule in the
inoculum (Bol et al., 1971). This early function of CP in the
inoculum has been termed “genome activation” and was
subsequently found also to be required for the initiation1 To whom reprint requests should be addressed at Einsteiweg 55,
333 CC Leiden, The Netherlands. E-mail: j.bol@chem.leidenuniv.nl.
29of infection by a number of ilarviruses (reviewed in Bol,
1999). In addition to its function in the inoculum, AMV CP
is required to permit asymmetric accumulation of plus-
strand viral RNA. This function was first observed in
studies on the replication of AMV RNA 3 in tobacco
plants (P12 plants) transformed with the P1 and P2 rep-
licase genes, encoded by AMV RNAs 1 and 2, respec-
tively. RNA 3 encodes the movement protein P3 and the
viral CP, which is translated from a subgenomic messen-
ger, RNA 4. When the expression of the CP gene is
abolished, accumulation of plus-strand RNA 3 in proto-
plasts of P12 plants is reduced about 100-fold but no
effect on the accumulation of minus-strand RNA 3 is
observed (van der Kuyl et al., 1991; van der Vossen et al.,
1994). A mutational analysis of the CP gene provided
evidence that the reduction in accumulation of plus-
strand RNA is due to a reduced synthesis rather than to
an enhanced degradation of the RNAs (van der Vossen
et al., 1994). Using a purified AMV-specific RNA-depen-
dent RNA-polymerase (RdRp), it has been shown that CP
strongly stimulates plus-strand RNA 4 synthesis on a
minus-strand RNA 3 template (de Graaff et al., 1995). An
analysis of the replication of CP mutants in plants re-
vealed that in addition to its functions in genome activa-
tion, plus-strand RNA synthesis, and encapsidation, CP
was also required for cell-to-cell movement of AMV (van
der Vossen et al., 1994).
An intriguing question is whether the multiple roles of
AMV CP are carried out by a single domain of this CP or
point to different functional protein domains. In solution,
AMV CP occurs as dimers (Kruseman et al., 1971), and
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30 TENLLADO AND BOLthis dimer is the structural building block of the viral
capsids (Kumar et al., 1997). At their 39 termini, AMV
NAs contain a homologous sequence of 145 nucleo-
ides (nt) that can be folded into a number of stem-loop
tructures interspersed by single stranded AUGC se-
uences. These stem-loop structures and flanking AUGC
otifs represent high-affinity binding sites for CP, and
ach genomic RNA in the inoculum must be complexed
ith a few CP dimers to initiate infection (see Bol, 1999).
minimal binding site is located in the 39 terminal 39 nt
f the AMV RNAs (Houser-Scott et al., 1994; Reusken and
ol, 1996). Synthetic peptides corresponding to the
-terminal 25, 26, or 38 amino acids (aa) of AMV CP are
unctional in genome activation, and two copies of the
eptides bind specifically to overlapping binding sites in
n RNA fragment corresponding to the 39 39 nt of AMV
NAs (Baer et al., 1994; Ansel-McKinney and Gehrke,
998). Mutation of Arg-17 of AMV CP to alanine interfered
ith binding of these peptides to the 39 39 nt sequence
nd with the ability of CP to activate the genome (Ansel-
cKinney et al., 1996; Yusibov and Loesch-Fries, 1995,
998). A C-terminal deletion of 21 aa interfered with the
ole of CP in virion assembly in vivo (van der Vossen et
al., 1994). Recently, it was shown that this C-terminal
domain participates in CP dimer formation and T equals
one particle assembly in vitro (Choi and Loesch-Fries,
1999).
We proposed that the binding of CP to inoculum RNAs
could play a role during translation of these RNAs and
that the binding of newly synthesized CP to the 39 end of
plus-strand RNAs induces a conformational change in
the RNA that switches off minus-strand RNA synthesis
(Neeleman and Bol, 1993; Olsthoorn et al., 1999). In a
later stage of the infection cycle, cooperative binding of
CP to multiple 39 terminal binding sites could initiate
encapsidation of the RNAs to permit virion formation and
cell-to-cell transport. On the surface of infected proto-
plasts, AMV P3 assembled into tubular structures that
appeared to be filled with virus particles, suggesting a
mechanism of tubule-guided movement of AMV virions
through modified plasmodesmata (Kasteel et al., 1997).
As an alternative to the above model for early functions
of CP, it has been proposed that binding of CP to inoc-
ulum RNAs permits recruitment of the CP by the RdRp
and that binding of CP to the RdRp changes the speci-
ficity of the enzyme complex toward plus-strand RNA
synthesis (de Graaff et al., 1995). In a third model, it was
proposed that the binding of CP to AMV RNAs results in
a positioning of the 39 terminal nucleotide in the correct
orientation for initiation of replication (Houser-Scott et al.,
1997).
To further dissect functional domains in AMV CP, we
engineered a number of novel mutations in this protein.
The effect of these mutations on the ability of CP to form
dimers was assayed by the two-hybrid system. In addi-
tion, these mutations were engineered in an infectious
N
rclone of AMV RNA 3, and their effect on genome activa-
tion, plus-strand RNA synthesis, virion formation, cell-to-
cell movement and systemic movement of the virus was
determined. The results support the notion that functions
of CP in each of these steps of the replication cycle can
be mutated separately.
RESULTS
CP domains involved in CP–CP interaction
Figure 1 shows a schematic representation of the CP
mutants used in this study. The WT CP (CPWT) is 220 aa
long and is acetylated at its N-terminal serine (van Bey-
num et al., 1977). To determine whether CP dimer forma-
tion was detectable by the two-hybrid system, WT CP
genes were fused to the activating domain (AD) of GAL4
in vector pGAD424 (pADCP) and the DNA binding do-
main (BD) of GAL4 in vector pGBT9 (pBCP). When the
empty vectors or pADCP or pBCP were expressed sep-
arately in yeast SFY525 cells, the colonies remained
white in a b-galactosidase (b-Gal) filter assay (Fig. 2).
owever, when pADCP and pBCP were introduced to-
ether into yeast cells, a dark blue staining was ob-
erved, reflecting a strong CP–CP interaction (Fig. 2, top
eft colony). To identify the domains involved in this
nteraction, mutant CP genes were fused to both the AD
nd BD of GAL4. Figure 2 shows the interactions ob-
erved with a combination of WT CP fused to AD and
utant CP fused to BD; similar results were obtained
ith the reverse combinations (result not shown). For
ach combination, two transformed cells of at least three
ndependent transformations were tested with reproduc-
ble results.
To analyze the role of the C-terminal domain of CP in the
P–CP interaction, the effect of C-terminal deletions was
nvestigated. A deletion of 7 aa did not affect the CP–CP
nteraction (mutant CPN213), a deletion of 14 aa reduced
he interaction (mutant CPN206), and no detectable inter-
ction was observed with C-terminal deletions of 21 or 40
a (mutants CPN199 and CPN180) (results are shown in
ig. 2 and summarized in Table 1). Also, CP with longer
-terminal deletions was unable to interact with WT CP in
he two-hybrid system (mutants CPN85 and CPN63; sum-
arized in Table 1). In agreement with the results of Choi
nd Loesch-Fries (1999), it is concluded that except for the
erminal 7–14 aa, the C-terminal domain of CP is involved in
he CP–CP interaction. N-terminal deletions of CP were
ade to analyze a possible role of the N-terminal domain in
P–CP interaction. A deletion of 4 aa did not affect the
P–CP interaction (mutant CPDN4), but N-terminal dele-
ions of 10, 16, and 25 aa slightly reduced the interaction as
bserved in the two-hybrid system (mutants CPDN10,
PDN16, and CPDN25) (results are shown in Fig. 2 and
ummarized in Table 1). It is concluded that the basic
-terminal arm of AMV CP plays a limited but significant
ole in the CP–CP interaction. Mutation of basic residues at
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31MULTIPLE FUNCTIONS OF AMV CPpositions 13, 16, 17, 16 and 17, or 25 into alanine in this
N-terminal arm did not interfere with the CP–CP interaction
(mutants CPK13A, CPK16A, CPR17A, CPR16K17, and
CPR25A), although the interaction obtained with the
CPR17A mutant was consistently lower than that obtained
with WT CP (Fig. 2, Table 1). Apparently, replacement of
Arg-17 by alanine weakens the CP–CP interaction but re-
placement by lysine in mutant CPR16K17 does not.
Previously, we showed that CP of mutant CP4P (Arg-85
and Ile-86 replaced by the nonviral sequence Pro-Ala-
Gly-Leu-Gln-Val) was fully functional in genome activa-
tion and plus-strand RNA synthesis but defective in en-
capsidation of viral RNA (van der Vossen et al., 1994).
Figure 2 shows that mutant CP4P did not interact with
WT CP in the two-hybrid system. Amino acids 67, 117, and
174 are located in predicted loops of CP that protrude
from the surface of the virions (Kumar et al., 1997). Mu-
ation of aa 67 and 117 into alanine (mutants CPN67A,
PD117A) or aa 174 into proline (CPA174P) did not affect
P dimer formation in the two-hybrid system (Fig. 2,
able 1).
In addition to mutant-CP/WT-CP interactions, we also
FIG. 1. Schematic representation of mutant CP constructs. (A) CP mu
genes. Numbers at the 59 or 39 end of the boxes indicate the bordering
acids at position 85 of the CP gene. The D sign in the name of the muta
utants containing amino acid substitutions (CPK13A: Lys-13 replaced
r deletions within aa 1–25 is given. Basic residues are underlined innalyzed mutant-CP/mutant-CP homodimer interactions
n the two-hybrid system (results not shown). Interactions
f
ihat were scored as “WT” (11) in the mutant-CP/WT-CP
ssay were also scored as WT in the mutant-CP/mu-
ant-CP assay with the exception of mutant CPK13A,
hich showed a slightly reduced interaction in the latter
ype of assay (scored as “1”). However, interactions that
ere scored as “reduced” (1) in the first type of assay
i.e., mutants CPDN10, CPDN16, CPDN25, CPN206, and
PR17A) were scored as “negative” (2) in the second
ype of assay. Apparently, the effects of these mutations
dd up when they are present in both subunits of one CP
imer. Finally, interactions that were scored as “negative”
n the first type of assay were also “negative” in the
econd type of assay.
ccumulation of CP mutants in P12 plants
To further analyze functional domains in AMV CP,
utations were introduced in the CP gene in a full-length
nfectious clone of RNA 3, and the replication of the
utant RNA 3 molecules was analyzed in P12 tobacco
lants transformed with the AMV P1 and P2 genes. In
ontrast to nontransgenic plants, P12 plants can be in-
ith N- or C-terminal deletions. Boxes represent the WT and mutant CP
acid; the black triangle in CP4P represents a net insertion of 4 amino
icates a deletion of the corresponding N-terminal amino acids. (B) CP
nine and so on). The N-terminal sequence of mutants with mutations
CP sequence. Amino acid substitutions are in bold italics.tants w
amino
nts indected with RNA 3 without the requirement for CP in the
noculum (Taschner et al., 1991). Therefore, this system
w
G
n ctor wi
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32 TENLLADO AND BOLcan be used to study possible CP mutants that are
defective in genome activation. Figure 3A shows a North-
ern blot analysis of the accumulation of encapsidated
RNAs of a number of CP mutants in P12 plants; similar
results were obtained with these mutants when total
RNA extracts from the plants were analyzed (not shown).
In addition to RNAs 3 and 4, the RNA extracts contain a
few prominent degradation products of RNA 3 (van der
Vossen et al., 1994). Mutation of Arg-17 into alanine or
deletion of the N-terminal 16 aa of CP abolished virus
accumulation (Fig. 3A, lanes 5 and 13), whereas mutation
of lysine or arginine at positions 13, 16, and 25 into
alanine (Fig. 3A, lanes 3, 4, and 6) or deletion of the
N-terminal 10 aa (Fig. 3A, lane 11) had little effect on virus
accumulation. The reduced accumulation of mutant
CPK13A was not reproducibly observed in other experi-
ments; see also mutant CPDN10K13,16A (Fig. 3A, lane
12). Together, the results indicate that basic aa at posi-
tions 5, 6, 10, 13, 16, and 25 of CP are not essential for
AMV RNA replication, encapsidation, or cell-to-cell
movement. However, N-terminal deletions of 4 or 10 aa
and point mutations at positions 13 and 16 affected
symptom formation as indicated in Table 1.
Mutation of Asn-67 and Ala-174 in predicted loops of
CP at the surface of virions did not affect accumulation of
virus particles (Fig. 3A, lanes 7 and 9) or symptom for-
mation (Table 1), but mutation of Asp-117 to alanine
caused a strong hypersensitive response (HR) of the
FIG. 2. AMV CP–CP interactions assayed by the yeast two-hybrid syst
ith the GAL4 DNA binding domain together with WT CP fused to
AL4-mediated activation of b-Gal activity present in doubly transfo
itrocellulose filter is shown. As controls, yeast cells containing the ve
ector with the GAL4 DNA binding domain (22) are shown. Yeast cellsplant resulting in the formation of local lesions on the
inoculated leaves of P12 tobacco plants (Table 1). Thelow level of virus accumulation that was observed for
mutant CPD117A (Fig. 3A, lane 8) indicates that the HR
prevented spread of the mutant from the site of infection.
It should be noted that infection of P12 plants with WT
RNA 3 of AMV isolate 425 results in the accumulation of
at least 0.5 mg of virus/g of leaf material without produc-
tion of detectable symptoms.
Previously, we showed that CP of mutant CPN199 with
a C-terminal deletion of 21 aa was unable to encapsidate
AMV RNA, but the RNA of this mutant accumulated in
P12 plants at a level that was about 1–5% of the WT
accumulation (van der Vossen et al., 1994). Here we
compared the replication of this mutant with three addi-
tional mutants lacking 7, 14, and 40 aa from the
C-terminus. Figure 3B shows an analysis of total RNA
extracts from leaves of P12 plants inoculated with these
mutants, whereas Fig. 3C shows RNAs isolated from
virions purified from these leaves. Mutant CPN213 with a
C-terminal deletion of 7 aa accumulates as viral parti-
cles, but accumulation of mutant CPN206 is detectable
only in the total RNA extract. Apparently, the C-terminal
deletion of 14 aa interfered with encapsidation. Accumu-
lation of mutants CPN199 and CPN180 was just above
the detection level and was seen in a few experiments
but not in the experiment shown in Fig. 3B.
CP mutants that were able to accumulate in the inoc-
ulated leaves of P12 plants were assayed for systemic
movement by Northern blot analysis of total RNA ex-
tant CP constructs were introduced into yeast SFY525 cells as a fusion
L4 transcriptional activation domain. Interactions were assayed by
cells. A diagram of the arrangement of yeast transformants on the
th WT CP only (2) or containing the vector with WT CP plus an empty
ncubated for 24 h at 30°C. The colorimetric substrate X-Gal was used.em. Mu
the GA
rmedtracted from noninoculated upper leaves. Figure 4 shows
the RNAs extracted 14 days after inoculation; similar
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33MULTIPLE FUNCTIONS OF AMV CPresults were obtained with RNA samples isolated 7 days
after inoculation. Mutants CPK13A, CPK16A, CPN67A,
and CPDN10 were able to move systemically at WT
levels, whereas systemic movement of CPA174P was
consistently reduced. However, accumulation of mutants
CPR25A, CPD117A, CPDN10K13,16A, CPN213, and
CPN206 was not detectable in noninoculated leaves.
Virions of mutants CPDN10K13,16A, CPR25A, and
CPN213 accumulated at WT or near WT levels in inocu-
lated leaves, indicating that their mutations selectively
affected systemic movement. For mutants CPN180,
CPN199, CPN206, and CPD117A, their low level of accu-
mulation in the inoculated leaf could have affected sys-
temic spread. The data are summarized in Table 1.
Replication and encapsidation of CP mutants in P12
protoplasts
T
Summary of the Pr
Mutant
Genome
activation
P12 protoplasts
(1) RNA synthesis Virion formation
WT 11 11 11
DN4/DN5* 11 11 11
DN10 11 ND ND
N10K13, 16A 11 ND ND
N16 2 11 11
N20* 2 2 2
N25 ND ND ND
63* 2 2 ND
N85* 2 2 ND
N180 2 11/1 2
N199 1 11/1 2
N206 ND 11/1 2
N213 ND 11 11
K13A 11 ND ND
K16A 11 ND ND
R17A 2 11 11
R16K17 ND 11 ND
R25A 11 11 11
67A 11 ND ND
117A 2 11 1
174P 11 ND ND
P* 11 11 2
AUG* NA 2 2
a From left to right, the columns represent the relative levels of genom
nd systemic spread in P12 plants, symptoms exhibited by P12 plants
evels of accumulation of viral material and genome activation are repr
D, not determined, NA, not applicable. An asterisk refers to CP muta
b Infection of P12 plants with WT RNA3 does not induce detectable
symptoms.
c b-Gal filter assays were scored as follows: 2, no visible reactio
overnight development; 11, strong reaction that developed within 6 hMutants that accumulated at low or undetectable lev-
els in P12 plants were used to inoculate P12 protoplasts.Figures 5A and 5C show the accumulation of plus-strand
RNAs in mutant-infected protoplasts using WT RNA 3
and mutant CPR25A as positive controls. In Figs. 5B and
5D, the encapsidation of the mutant RNAs was analyzed
by loading Northern blots with homogenates of infected
protoplasts. Virus particles in such homogenates run as
a single band on the blot. Although mutants CPR17A and
CPDN16 did not accumulate in P12 plants, they showed
WT levels of plus-strand RNA accumulation in proto-
plasts (Fig. 5A) and the RNAs were encapsidated by the
mutant CP (Fig. 5B). Mutant CPD117A caused a strong
hypersensitive response in P12 plants but accumulated
at WT levels in P12 protoplasts (Fig. 5A), although virion
formation appeared to be somewhat reduced (Fig. 5B).
The C-terminal deletion mutant CPN213 accumulated at
WT levels and was encapsidated (Figs. 5C and 5D).
Compared with the accumulation of WT RNA 3, the ac-
cumulation of mutant CPN199 in protoplasts has been
s of CP Mutantsa
P12 plants
Two-hybrid assay
pread Systemic spread Symptomsb
WT CP–mutant
CP interactionc
11 2 11
ND Necrotic lesions 11
11 Chlor. rings/mosaic 1
2 Necrotic ringspot ND
ND 2 1
ND 2 ND
ND ND 1
ND 2 2
ND 2 2
2 2 2
2 Chlor. lesions 2
2 2 1
2 2 11
11 Necrotic veins 11
11 Necrotic veins 11
ND 2 1
ND 2 11
2 2 11
11 2 11
2 Necrotic lesions (HR) 11
6 2 11
ND 2 2
ND 2 NA
vation, accumulation in P12 protoplasts of viral RNAs and virions, local
P–CP interaction as revealed by the two-hybrid system. Approximate
d by 11, 100–50% (WT); 1, 50–10%; 6, 10–0%; and 2, not detectable.
scribed in van der Vossen et al. (1994).
toms; a minus sign indicates that the inoculated plant did not show
overnight incubation; 1, weak but consistent reaction that required
ot applicable; ND, not determined.ABLE 1
opertie
Local s
11
11
11
11
2
2
ND
2
2
6
6
1
11
11
11
2
2
11
11
6
11
2
2
e acti
, and C
esente
nts de
sympreported to vary from low to near WT levels (van der
Vossen et al., 1994; Neeleman and Bol, 1999). A similar
utant C
34 TENLLADO AND BOLvariation was observed for mutants CPN206 and
CPN180. Figure 5C shows an experiment with relatively
low levels of accumulation of mutants CPN206, CPN199,
and CPN180. An experiment with a relatively high level of
accumulation of mutant CPN180 is shown in Fig. 5A, lane
4. These C-terminal deletion mutants were largely defec-
tive in encapsidation. All mutants analyzed in Fig. 5
induced the accumulation of WT levels of CP in proto-
plasts (result not shown). Thus defects in encapsidation
FIG. 3. Accumulation of AMV RNAs 3 and 4 in inoculated leaves of P1
virus particles (A and C) and total RNA (B) were analyzed by Northern bl
with RNA 3 transcripts containing the WT CP gene or the indicated m
positions of RNAs 3 and 4 are indicated in the left margin.
FIG. 4. Accumulation of viral RNAs in systemically infected leaves of
3 transcripts containing the indicated mutant CP genes (lanes 1–11) or
leaves and analyzed by Northern blot hybridization using a DIG-labeled RNA
positions of RNAs 3 and 4 are indicated in the left margin.are not a consequence of reduced availability of the
mutant CP. On electron microscopy, no viral particles
were detectable in leaf dips of plants or homogenates of
protoplasts infected with mutant CPN199 (data not
shown), but we cannot rule out the possibility that un-
stable mutant particles were degraded during sample
preparation. The data on plus-strand RNA synthesis and
virion formation by the various mutants are summarized
in Table 1.
inoculated with CP mutants. RNA preparations extracted from purified
idization using a DIG-labeled RNA 3 probe. The plants were inoculated
P genes. Mock, RNA extracted from mock-inoculated P12 plants. The
nts inoculated with CP mutants. The plants were inoculated with RNA
CP gene (lane 13). Total RNA was extracted from upper noninoculated2 plants
ot hybrP12 pla
the WT3 probe. Mock, RNA extracted from mock-inoculated P12 plants. The
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35MULTIPLE FUNCTIONS OF AMV CPComplementation studies with mutant CPR17A and
analysis of mutant CPR16K17
Because it was previously shown that mutation of
Arg-17 to alanine interfered with the binding of N-termi-
nal peptides or full-length AMV CP to viral RNA (Ansel-
McKinney et al., 1996; Yusibov and Loesch-Fries, 1998),
ur finding that mutant CPR17A formed stable virions in
rotoplasts was unexpected. To rule out the possibility
hat the mutant had reverted to WT, we analyzed the
rogeny RNAs produced in protoplasts by RT-PCR. This
trategy was based on the fact that the CPR17A mutation
ntroduced an HindIII restriction site that was absent in
he WT cDNA. In addition, we used the same strategy to
nalyze a possible complementation of the defect in
ell-to-cell movement of mutant CPR17A in a mixed in-
ection of P12 plants with WT RNA 3.
To test the stability of mutant CPR17A, P12 protoplasts
ere inoculated with the mutant alone or with a mixture
f mutant and WT RNA 3. Eighteen hours after inocula-
ion, RNA was extracted from the protoplasts and used
s template in an RT-PCR assay using oligonucleotides
L4 and 626 (see Materials and Methods) as primers.
hen this RT-PCR assay was performed with RNA ex-
racted from P12 plants infected with WT RNA 3, a single
023-bp fragment was obtained that was resistant to
igestion with HindIII (Fig. 6, lane 3). However, the frag-
ent obtained with RNA from CPR17A-infected proto-
lasts was digested with HindIII into the expected frag-
FIG. 5. Accumulation of viral RNAs and virions in P12 protoplasts
ranscripts containing the WT CP gene or the indicated mutant CP gen
NAs extracted from the protoplasts (A and C) or with homogenates of
ock-inoculated P12 protoplasts. The positions of virions (V) and glyoxents of 802 and 221 bp, demonstrating that the mutant
as able to replicate in protoplasts (Fig. 6, lane 7). Thepresence of the CPR17A mutation in the 1023-bp frag-
ment was confirmed by sequence analysis. In the mixed
infection of P12 protoplasts, both WT RNA 3 and mutant
ated with CP mutants. The protoplasts were inoculated with RNA 3
incubated for 18 h. The Northern blots were loaded with glyoxylated
oplasts containing virus particles (B and D). Mock, RNA extracted from
RNAs 3 and 4 are indicated in the right and left margins, respectively.
FIG. 6. Analysis of the complementation of transport-defective CP
mutant CPR17A by WT CP. P12 plants (lanes 1–6) and protoplasts
(lanes 7 and 8) were inoculated with WT RNA 3 (lane 3), mutant CPR17A
(lanes 4 and 7), and a mixture of WT RNA 3 and mutant CPR17A (lanes
5, 6, and 8). Total RNA extracted from protoplasts and RNA extracted
from virions that had been isolated from plants were analyzed by
RT-PCR using primers specific for the CP gene. The identity of the viral
progeny was tested by digestion of the amplified cDNA fragment with
HindIII, a restriction site presents only in cDNA of mutant CPR17A.
Lane 1, l EcoRI–HindIII molecular weight markers. Lane 2, RNA ex-
tracted from mock-inoculated P12 plants. The length (bp) of the ampli-inocul
es andfied cDNA fragment and the HindIII digestion products is indicated in
the right margin.
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36 TENLLADO AND BOLCPR17A were detectable by the RT-PCR assay (Fig. 6,
lane 8).
When P12 plants were inoculated with mutant
CPR17A, no accumulation of the mutant or possible re-
vertants was detected by RT-PCR in the inoculated leaf
(Fig. 6, lane 4). In a complementation assay, P12 plants
were inoculated with a mixture of CPR17A and WT RNA
3. When RNA extracted from the inoculated leaves was
used as template in an RT-PCR assay, a 1023-bp frag-
ment was obtained that was resistant to HindIII digestion
(Fig. 6, lanes 5 and 6). Apparently, only the WT RNA 3 in
the inoculum had infected the plant, and WT CP ex-
pressed from this RNA did not complement the defect in
cell-to-cell movement of mutant CPR17A.
To analyze the importance of the side chains of the
basic residues at positions 16 and 17 of AMV CP, the
lysine at position 16 and the arginine at position 17 were
reversed in mutant CPR16K17. Figure 7A shows that in
P12 protoplasts, the mutant accumulated at levels com-
parable to that of mutant CPR17A or WT RNA 3. However,
similar to mutant CPR17A, mutant CPR16K17 was defec-
tive in accumulation in P12 plants (Fig. 7B).
Genome activation by mutant CP
Infection of nontransgenic plants by a mixture of AMV
RNAs 1, 2, and 3 can be initiated by the addition of either
CP or the subgenomic messenger for CP, RNA 4. Be-
cause it was not possible to isolate CP from virus parti-
cles of mutants that did not accumulate in plants or were
not encapsidated by the mutant CP, we assayed the
ability of mutant CP to activate a WT genome by adding
T7 RNA polymerase transcripts of mutant cDNA 4 clones
FIG. 7. Accumulation of viral RNAs in P12 protoplasts and plants
noculated with WT RNA 3 or mutants CPR17A and CPR16K17. Total
NA was extracted from the protoplasts (A) and from the inoculated
eaves of the plants (B) and analyzed by Northern blot hybridization
sing a DIG-labeled RNA 3 probe. Mock, RNA extracted from mock-
noculated P12 protoplasts or plants. The positions of RNAs 3 and 4 are
ndicated in the left margin.to WT RNAs 1, 2, and 3 and inoculating the mixture to
nontransgenic Nicotiana benthamiana plants. To avoid tthe presence of contaminating WT RNA 4, RNAs 1, 2, and
3 were transcribed with T7 RNA polymerase from corre-
sponding cDNA clones (Neeleman and Bol, 1999). In a
cell-free reticulocyte system, RNA 4 transcripts of all
mutants were translated into CP as efficiently as a WT
RNA 4 transcript (results not shown). RNA 4 transcripts of
each mutant were tested at least in three independent
genome activation assays; in addition, assays with mu-
tants CPR25A and CPA174P were also performed with
native RNA 4 purified from mutant-infected P12 plants.
Figure 8 shows a Northern blot analysis of total RNA
extracted from the inoculated leaves of the plants. The
accumulation of AMV RNAs in plants inoculated with WT
RNAs 1–4 is shown in Fig. 8, lane 1. When the initiation
codon of the CP gene in WT RNA 4 in the inoculum is
changed from AUG into AAG, CP expression is abolished
and RNAs 1, 2, and 3 are no longer able to initiate
infection (Fig. 8, lane 2). Genome activation by the mutant
RNA 4 molecules that were tested is shown in lanes 3–13
of Fig. 8. WT levels of genome activation were observed
with mutants CPK13A, CPK16A, CPR25A, CPN67A,
CPA174P, CPDN10, and CPDN10-K13,16A, whereas ge-
nome activation by mutants CPR17A and CPDN180 was
reduced to a barely detectable level (visible after longer
exposure of the blot) and no detectable activation was
obtained with mutants CPD117A and CPDN16. The data
are summarized in Table 1.
DISCUSSION
The results obtained in this study are summarized in
Table 1. The function of CP of mutants indicated by an
asterisk in genome activation and virus replication in P12
protoplasts and plants were determined previously (van
der Vossen et al., 1994) and are included for comparison.
In the present work, CP of these mutants was only used
to study CP–CP interactions in the two-hybrid system.
CPs of alfamoviruses and ilarviruses are interchange-
able in the phenomenon of genome activation and bind
reciprocally to the 39 termini of genomic RNAs of viruses
from these two genera. The observation that synthetic
peptides corresponding to N-terminal sequences of CP
of AMV and tobacco streak ilarvirus specifically bind to
the 39 end of AMV and tobacco streak ilarvirus RNAs and
confer infectivity to a mixture of genomic RNAs shows
that the N-terminal arm of CP is sufficient for genome
activation and suggests that dimer formation of CP is not
required in this step of the replication cycle (Swanson et
al., 1998; Ansel-McKinney and Gehrke, 1998). In agree-
ment with this notion, we found that mutant CP that is
defective in dimer formation as measured by the two-
hybrid system can be fully (mutant CP4P) or partially
(mutant CPN199) functional in genome activation. AMV
CP with the N-terminal arm of 25 aa deleted is able to
assemble into empty T 5 1 spherical particle, indicating
hat this arm is dispensable for dimer formation (Bol et
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37MULTIPLE FUNCTIONS OF AMV CPal., 1974). However, deletion of this arm in mutant
PDN25 reduced the CP–CP interaction observed in the
wo-hybrid system. Structural studies by Kumar et al.
1997) indicated that in the CP dimer, the C-terminal arm
f one subunit is hooked around the N-terminal arm of
he twofold related subunit and that the dimer is further
tabilized by interactions between the C-terminal arms at
he icosahedral twofold axis. In agreement with this, we
ound that the C-terminal domain of CP is involved in the
P–CP interaction, although the C-terminal 7–14 aa are
ispensable for this interaction. Using a glutaraldehyde
ross-linking assay, Choi and Loesch-Fries (1999) con-
luded that the last 9 aa of CP were dispensable for CP
imer formation but that the last 18 aa were not. These
ata are in agreement with our results with the two-
ybrid system. Replacement of aa 85 and 86 by six
onviral aa (mutant CP4P) interfered with the CP–CP
nteraction. This interference may be due to the exten-
ion of a loop at the CP/CP interface in the CP dimer that
rotrudes toward the C-terminus (Kumar et al., 1997).
Although mutations that reduced or abolished CP–CP
nteractions in the two-hybrid system had little effect on
enome activation, they generally interfered with virion
ormation in protoplasts. This conclusion holds for the
-terminal deletion mutants CPN206, CPN199, and
PN180 and mutant CP4P. In agreement with our obser-
ations made in vivo, it was shown by Choi and Loesch-
ries (1999) that a C-terminal deletion of 18 aa interfered
ith assembly of T 5 1 particle in vitro, whereas deletion
f the last 9 aa did not. Evidence has been provided that
wo N-terminal peptides of AMV CP can bind simulta-
FIG. 8. Activation of the WT AMV genome by mutant RNA 4 transcrip
transcripts containing the WT CP gene (lane 1) or the indicated muta
was extracted from inoculated leaves and analyzed by Northern blot hyb
1, 2, and 3. In mutant DAUG, the CP ORF was eliminated by changing t
indicated in the left margin.eously to an RNA fragment corresponding to the 39
erminal 39 nt of AMV RNAs (Ansel-McKinney andehrke, 1998). Possibly, this 39 end of the RNA can also
ind two full-length CP monomers that have a functional
-terminal arm but are defective in dimer formation.
uch complexes may be functional in genome activation
arly in the replication cycle, but virion formation later in
he infection cycle possibly requires functional CP–CP
nteractions. Previously, the relatively low levels of AMV
enome activation that were obtained with RNA 4 tran-
cripts that could be translated into peptides corre-
ponding to the N-terminal 63 or 85 aa of CP (mutants
PN63 and CPN85) was attributed to a possible insta-
ility of the peptides in vivo (van der Vossen et al., 1994).
A similar instability may explain the low activity of mutant
CPN180 in genome activation.
The replacement of the lysine residues at positions 5,
6, 10, 13, 16, or 25 by alanine did not affect the binding of
N-terminal peptides to the 39 end of AMV RNAs, but
replacement of Arg-17 by alanine or lysine abolished this
binding (Ansel-McKinney et al., 1996). We observed that
the replacement of Arg-17 by alanine, but not by lysine,
weakened the CP–CP interaction. In agreement with the
results of Yusibov and Loesch-Fries (1998), we found that
mutant CPR17A was largely defective in genome activa-
tion. A similar phenotype was found for the N-terminal
deletion mutant CPDN16. Interestingly, CP of mutants
CPR17A and CPDN16 was fully functional in plus-strand
RNA synthesis and virion formation. In addition to the 39
termini of AMV RNAs, CP has been shown to bind to
internal sequences of RNAs 1–4 (Zuidema and Jaspars,
1984). We cannot rule out the possibility that these inter-
nal CP binding sites act as the origin of assembly for
scripts corresponding to AMV RNAs 1, 2, and 3 were mixed with RNA
enes (lanes 2–13) and inoculated to N. benthamiana plants. Total RNA
ion using a mixture of DIG-labeled probes corresponding to AMV RNAs
tion codon from AUG to AAG. The positions of RNAs 1, 2, 3, and 4 arets. Tran
nt CP g
ridizatvirion formation and are still recognized by CP of mutants
CPR17A and CPDN16. Alternatively, the affinity of these
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38 TENLLADO AND BOLmutant CPs for the 39 terminal binding sites in AMV
RNAs is reduced to levels that are not detectable by
bandshift assays. Such a reduced affinity could interfere
with genome activation early in infection when CP levels
are low but could still permit virion formation when CP
levels rise later in the infection cycle. Before virion for-
mation, binding of the mutant CP to the 39 end could
trigger the conformational switch in the RNA that has
been proposed to play a role in asymmetric plus-strand
RNA synthesis (Olsthoorn et al., 1999). Apparently, asym-
metric synthesis of plus-strand RNA can be supported by
mutant CPs that are either defective (mutant CP4P) or
functional in virion formation (e.g., mutants CPR17A and
CPDN16). Previously, we observed that CP with an
N-terminal deletion of 20 aa was defective in plus-strand
RNA accumulation (van der Vossen et al., 1994). Appar-
ntly, a determinant in aa 17–20 is critical for plus-strand
NA accumulation (compare mutants CPDN16 and
PDN20 in Table 1).
CP of mutants that did not form stable virus particles in
rotoplasts were either nonfunctional in cell-to-cell
ovement (CP4P) or permitted low levels of spread in
noculated leaves of P12 plants (CPN180, CPN199, and
PN206). Possibly, the latter type of mutants form CP–
NA complexes that are degraded on homogenization of
rotoplasts in the encapsidation assay but can be trans-
orted from cell to cell through tubules consisting of the
3 movement protein (Kasteel et al., 1997). On the other
and, mutants CPR17A and CPDN16 assembled into
particles that were indistinguishable from WT virions by
their migration in agarose gels but were unable to
spread locally. Possibly, CP of these mutants could be
defective in an interaction with host or viral proteins
involved in tubule-guided transport. CP of mutant CP4P
could be defective in functions required for both encap-
sidation and interaction with the transport machinery.
Previously, we reported that CP is required in cis for
ccumulation and encapsidation of AMV RNA 3 (Neele-
an and Bol, 1999). This conclusion was based on the
inding that coinoculation of nontransgenic protoplasts
ith WT RNA 3 and CP mutants defective in either step
f the replication cycle resulted in complementation of
he accumulation and encapsidation of RNAs 1 and 2 but
ot of the mutant RNA 3. The observation that the defect
n cell-to-cell movement of mutant CPR17A was not com-
lemented by coinfection of plants with WT RNA 3 indi-
ates that CP may also be required in cis for movement
f RNA 3. Finally, mutants CPDN10K13,16A, CPR25A, and
PN213 were able to spread at WT levels in the inocu-
ated leaves of P12 plants but were defective in systemic
ovement. Possibly, these N- or C-terminal mutations
ffect functions of CP required for entry into or exit from
he vascular system of viral material.
In summary, our results demonstrate that functions of
P of alfamoviruses, and possibly also ilarviruses, in the
nitiation of infection, plus-strand RNA synthesis, virionormation, cell-to-cell spread, and systemic movement in
lants can all be mutated separately. A common element
n these functions may be the requirement for binding of
P to the 39 termini of the viral RNAs. In addition, CP is
ikely to contain domains that interact with viral and/or
ost proteins involved in RNA replication and virus
pread that can be targets for mutagenesis.
MATERIALS AND METHODS
P mutants in the two-hybrid vectors
The AMV CP gene was excised from clone pAL3
Neeleman et al., 1991) with BspHI (position 1296 of
DNA 3) and PstI (downstream of cDNA 3) and fused
n-frame to the C-terminus of the GAL4 BD or AD in
lasmids pGBT9 and pGAD424, resulting in pBCP and
ADCP, respectively (Bartel et al., 1993a). Mutants CP4P,
PN63, CPN85, and CPN199 were introduced in pBCP
nd pADCP as described by van der Vossen et al. (1994).
Psp1406I restriction site at position 1348 in cDNA 3
as used to create a CP mutant with the N-terminal 16
a deleted. Cloning of the blunt Psp1406I–PstI fragment
f the CP gene into BamHI–PstI-digested pGBT9 or
GAD424 yielded mutant CPND16. The CP genes of
mutants CPDN4, CPDN10, and CPDN25 were amplified
by PCR with primers corresponding to the relevant posi-
tions of the WT CP gene, and the PCR products were
inserted in pGBT9 and pGAD424 as EcoRI–PstI frag-
ments. Similarly, the CP genes of mutants CP206 and
CPN213 were amplified by PCR and inserted as ApaI–
PstI fragments. Single aa substitutions were introduced
in the CP gene by two consecutive PCRs (Higuchi et al.,
1988) using the template pADCP, the 39 primer CL4, the
59 primer AD, and two specific primers for each mutant.
Primer CL4 contains a sequence complementary to the
39 end of RNA 3 that is extended with a PstI site; primer
AD corresponds to the 39-terminal end of the AD se-
quence and the EcoRI site of the multiple cloning site in
vector pGAD424. The substitution mutants CPK13A,
CPK16A, CPR17A, CPR16K17, and CPR25A were intro-
duced in plasmids pBCP and pACP by exchanging
EcoRI–SstI fragments; mutants CPN67A, CPD117A, and
CPA174P were introduced as EcoRI–BamHI or BamHI–
PstI fragments. The nucleotide sequence of all mutant
constructs was verified (Sambrook et al., 1989). This
showed that a few clones of mutant CPD117A contained
a deletion of A-1842 of cDNA 3, resulting in a frameshift
in the CP ORF after aa 180 and an in-frame stop codon
(nt 1914–1916) 24 codons downstream of aa 180. Re-
placement of the BamHI–PstI fragment of the WT CP
gene by the corresponding fragment of this frameshift
mutant resulted in mutant CPN180.
CP mutants in RNAs 3 and 4Mutant cDNA fragments were amplified by two con-
secutive PCRs (Higuchi et al., 1988) using the 59 primer
Tr
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39MULTIPLE FUNCTIONS OF AMV CP626 (nt 1126–1148 of cDNA 3), the 39 primer CL4, and two
primers specific for each mutant. Mutations CPK13A,
CPK16A, CPR17A, CPR16K17, CPR25A, CPDN10,
CPDN10-K13,16A, and CPDN16 were introduced in the
full-length RNA 3 clone pAL3 by exchanging the BclI–SstI
fragment of this clone (nt 1240–1493) with corresponding
mutant fragments. Other mutants were introduced in
pAL3 by replacement of SstI–ApaI fragments (nt 1493–
1902: mutants CPN67A, CPD117A, CPA174P, and
CPN180) with corresponding fragments of mutants
cloned in pGBT9. The RNA 3 clone with mutant CPN199
was made previously (van der Vossen et al., 1994).
Plasmid pT72-42 contains a full-length DNA copy of
RNA 4 behind the T7 promoter (Langereis et al., 1986)
and was used to generate RNA 4 mutants. Mutations
CPK13A, CPK16A, CPR17A, CPR25A, CPN67A, CPDN10,
CPDN10K13,16A, and CPDN16 were transferred from the
corresponding RNA 3 clones to pT72-42 as described by
van der Vossen et al. (1994). Mutations CPD117A,
CPA174P, and CPN180 were introduced into the RNA 4
clone by replacement of the SstI–ApaI fragment (nt 232–
641 of RNA 4) of pT7-42 with the SstI–ApaI fragment of
RNA 3 clones containing the respective mutations. The
construction of CPDAUG, in which a mutation of the
initiation codon of the CP gene interferes with CP ex-
pression, has been described previously (van der Vos-
sen et al., 1994).
Transformation of yeast
The yeast strain SFY525 (Bartel et al., 1993b) was
grown and transformed as described by Schiestl and
Gietz (1989). The cells were spread on 2% glucose-
containing minimal medium (Chien et al., 1991) lacking
leucine and tryptophan (selective medium). After 3 days
of growth, the yeast transformants were assayed for the
production of b-Gal activity by a filter colony lift assay as
described by Li et al. (1997).
In vitro RNA transcription
Transcription with T7 RNA polymerase of full-length
clones of AMV RNA 1 (pUT17A), RNA 2 (pUT27A), RNA 3
(pAL3), RNA 4 (pT72-42), and mutant clones was per-
formed as described previously (Neeleman and Bol,
1999; van der Vossen et al., 1994). RNA 4 transcripts were
translated in an mRNA-dependent rabbit reticulocyte ly-
sate system according to the manufacturer’s instructions
(Promega, Madison, WI). The synthesis of WT and mu-
tant CPs was assayed by Western blot analysis (Towbin
et al., 1979) using antiserum prepared against AMV CP.
Inoculation of plants and protoplasts
Inoculation of transgenic P12 tobacco plants with 25
ml of transcription mixture per half-leaf was done on at
least two half-leaves of two plants each per assay as
described (Taschner et al., 1991). Isolation and inocula-tion of P12 protoplasts were performed essentially as
reported previously (Loesch-Fries et al., 1985; van Dun et
al., 1988). Incubation of protoplasts was carried out for
18 h at 25°C under constant illumination. Nontransgenic
N. benthamiana plants were inoculated with transcrip-
tion mixtures containing WT RNAs 1, 2, and 3 and WT or
mutant RNA 4 (10 ml of transcription mixture per half-
leaf).
Analysis of inoculated plants and protoplasts
Virus particles were isolated 5 days after inoculation (d
p.i.) from inoculated leaves, and RNA was extracted from
these virus particles as described previously (van Vloten-
Doting and Jaspars, 1972). Total RNA was extracted from
inoculated leaves at 5 d p.i. and from noninoculated
upper leaves at 7 and 14 d p.i. as described by Verwoerd
et al. (1989). Total RNA was extracted from protoplast
samples using TRIzol reagent (GIBCO BRL, Grand Island,
NY) (van der Vossen et al., 1994). Total RNA from plants
(corresponding to 0.5 mg of leaf tissue) or protoplasts
(2 3 105 per sample) and RNA extracted from purified
virus particles (1 mg of leaf tissue) were denatured by
glyoxal/DMSO treatment and separated on 1.5% agarose
gels. Northern blot hybridization was carried out using
DIG-labeled (Boehringer-Mannheim Biochemicals, Indi-
anapolis, IN) riboprobes as described by Neeleman and
Bol (1999). Encapsidation of mutant RNAs into virus par-
ticles was analyzed by pelleting 0.5 3 105 protoplasts.
he protoplasts were resuspended in 100 ml of PE buffer
(0.01 M NaH2PO4 and 1 mM EDTA, pH 7.0) and incubated
for 20 min at room temperature to degrade the nonen-
capsidated RNAs (van der Vossen et al., 1994). After
centrifugation, 30 ml of the supernatant was electropho-
esed in a 0.8% agarose gel and analyzed by Northern
lot hybridization.
The progeny viral RNA from CP mutants was analyzed
y sequencing of the CP gene. Nucleotide sequences
ere determined on reverse transcriptase-PCR-ampli-
ied fragments by standard procedures (Sambrook et al.,
989). cDNA covering the entire CP gene was synthe-
ized on RNA extracted from virus particles using CL4
nd 626 as first- and second-strand primers, respec-
ively.
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